2-60768829-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_022894.4(PAPOLG):āc.377C>Gā(p.Ser126Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000069 in 1,449,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 33)
Exomes š: 6.9e-7 ( 0 hom. )
Consequence
PAPOLG
NM_022894.4 missense
NM_022894.4 missense
Scores
11
8
Clinical Significance
Conservation
PhyloP100: 0.683
Genes affected
PAPOLG (HGNC:14982): (poly(A) polymerase gamma) This gene encodes a member of the poly(A) polymerase family which catalyzes template-independent extension of the 3' end of a DNA/RNA strand. This enzyme shares 60% identity to the well characterized poly(A) polymerase II (PAPII) at the amino acid level. These two enzymes have similar organization of structural and functional domains. This enzyme is exclusively localized in the nucleus and exhibits both nonspecific and CPSF (cleavage and polyadenylation specificity factor)/AAUAAA-dependent polyadenylation activity. This gene is located on chromosome 2 in contrast to the PAPII gene, which is located on chromosome 14. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3993947).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PAPOLG | NM_022894.4 | c.377C>G | p.Ser126Cys | missense_variant | 5/22 | ENST00000238714.8 | |
PAPOLG | XM_005264500.5 | c.377C>G | p.Ser126Cys | missense_variant | 5/21 | ||
PAPOLG | XM_005264501.3 | c.245C>G | p.Ser82Cys | missense_variant | 5/22 | ||
PAPOLG | XR_007080681.1 | n.588C>G | non_coding_transcript_exon_variant | 5/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PAPOLG | ENST00000238714.8 | c.377C>G | p.Ser126Cys | missense_variant | 5/22 | 1 | NM_022894.4 | P1 | |
PAPOLG | ENST00000496283.5 | n.457C>G | non_coding_transcript_exon_variant | 5/19 | 1 | ||||
PAPOLG | ENST00000414060.5 | c.245C>G | p.Ser82Cys | missense_variant, NMD_transcript_variant | 5/21 | 1 | |||
PAPOLG | ENST00000453839.5 | c.359C>G | p.Ser120Cys | missense_variant, NMD_transcript_variant | 4/20 | 1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000816 AC: 2AN: 245048Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132410
GnomAD3 exomes
AF:
AC:
2
AN:
245048
Hom.:
AF XY:
AC XY:
2
AN XY:
132410
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 6.90e-7 AC: 1AN: 1449030Hom.: 0 Cov.: 29 AF XY: 0.00000139 AC XY: 1AN XY: 721052
GnomAD4 exome
AF:
AC:
1
AN:
1449030
Hom.:
Cov.:
29
AF XY:
AC XY:
1
AN XY:
721052
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 30, 2024 | The c.377C>G (p.S126C) alteration is located in exon 5 (coding exon 5) of the PAPOLG gene. This alteration results from a C to G substitution at nucleotide position 377, causing the serine (S) at amino acid position 126 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Loss of disorder (P = 0.0088);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at